title: Targeted therapy in the treatment of uterine serous carcinoma.
authors.affiliation: Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, Rm 305 LSOG, 333 Cedar St, PO Box 208063, New Haven, CT 06520, USA.
authors.forename: Carlton L
authors.initials: CL
authors.lastname: Schwab
authors.forename: Alessandro D
authors.initials: AD
authors.lastname: Santin
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D005784:Gene Amplification / Q000235:genetics; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects / Q000235:genetics; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human
keywords: HER2; PIK3CA; mTOR; targeted therapy; uterine serous carcinoma